<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <previousAccessionNumber>0000921895-26-000850</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Chernett Jorey -->
          <cik>0002042077</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>5</amendmentNo>
      <securitiesClassTitle>Common Stock, $0.01 par value</securitiesClassTitle>
      <dateOfEvent>11/13/2026</dateOfEvent>
      <previouslyFiledFlag>true</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001227636</issuerCIK>
        <issuerCusips>
          <issuerCusipNumber>64131A105</issuerCusipNumber>
        </issuerCusips>
        <issuerName>Neuronetics, Inc.</issuerName>
        <address>
          <com:street1>3222 PHOENIXVILLE PIKE</com:street1>
          <com:city>MALVERN</com:city>
          <com:stateOrCountry>PA</com:stateOrCountry>
          <com:zipCode>19355</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Jorey Chernett</personName>
          <personPhoneNum>(248) 469-8811</personPhoneNum>
          <personAddress>
            <com:street1>6222 Indianwood Tr.</com:street1>
            <com:city>Bloomfield Hills</com:city>
            <com:stateOrCountry>MI</com:stateOrCountry>
            <com:zipCode>48301</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0002042077</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Chernett Jorey</reportingPersonName>
        <fundType>PF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>2104026.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>2104026.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>2104026.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>2.7</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <commentContent>This Amendment No. 5 constitutes an exit filing for the Reporting Person, as the Reporting Person no longer beneficially owns more than five percent of the outstanding shares of the Issuer.</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, $0.01 par value</securityTitle>
        <issuerName>Neuronetics, Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>3222 PHOENIXVILLE PIKE</com:street1>
          <com:city>MALVERN</com:city>
          <com:stateOrCountry>PA</com:stateOrCountry>
          <com:zipCode>19355</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>This Amendment No. 5 to Schedule 13D ("Amendment No. 5") amends and supplements the Schedule 13D initially filed by the Reporting Person on March 31, 2026, as subsequently amended (the "Schedule 13D") with respect to the Shares. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Schedule 13D. As a result of the transactions described herein, the filing of this Amendment No. 5 represents the final amendment to the Schedule 13D and constitutes an exit filing for the Reporting Person.</commentText>
      </item1>
      <item3>
        <fundsSource>Item 3 is hereby amended and restated as follows:

The 2,104,026 Shares held by Mr. Chernett were purchased with personal funds for an aggregate purchase price of approximately $4,114,294, calculated on an average-cost basis.</fundsSource>
      </item3>
      <item5>
        <percentageOfClassSecurities>Item 5(a) is hereby amended and restated as follows:

The aggregate percentage of Shares beneficially owned by the Reporting Person is based upon 77,728,311 Shares outstanding as of October 28, 2026, as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed with the U.S. Securities and Exchange Commission (the "SEC") on November 4, 2026.

As of the close of business on November 13, 2026, the Reporting Person beneficially owned 2,104,026 Shares.

Percentage: Approximately 2.71%</percentageOfClassSecurities>
        <numberOfShares>Item 5(b) is hereby amended and restated as follows:

1. Sole power to vote or direct vote: 2,104,026
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 2,104,026
4. Shared power to dispose or direct the disposition: 0</numberOfShares>
        <transactionDesc>Item 5(c) is hereby amended and restated as follows:

The transactions in the Shares by the Reporting Person since the filing of Amendment No. 4 to the Schedule 13D are set forth in more detail in Exhibit 1 attached hereto.</transactionDesc>
        <listOfShareholders>Not applicable.</listOfShareholders>
        <date5PercentOwnership>The Reporting Person ceased to be the beneficial owner of more than 5% of the outstanding Shares on November 13, 2026.</date5PercentOwnership>
      </item5>
      <item7>
        <filedExhibits>Item 7 is hereby amended to add the following exhibits:

Exhibit 1 - Transactions in the Securities of the Issuer Since the Filing of Amendment No. 4 to the Schedule 13D</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Chernett Jorey</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Jorey Chernett</signature>
          <title>Jorey Chernett</title>
          <date>11/16/2026</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
